The SSMC HIV Conference 2027 invites healthcare professionals, clinicians, researchers, scientists, and academics to submit abstracts highlighting original research, clinical findings, innovative approaches, and emerging developments in HIV prevention, diagnosis, treatment, and patient-centered care.
Important Dates
Abstract Submission Deadline: 01 February 2027
Abstract Guideline
Abstract Submission Guidelines
Online Submission: All abstracts must be submitted through the official SSMC HIV Conference 2027 online abstract submission platform. Submissions via email or fax will not be accepted.
Language Requirements: Abstracts must be written in clear, professional English. All accepted abstracts must also be presented in English during the conference.
Scientific Review: All submitted abstracts will undergo evaluation by the Conference Committee based on scientific quality, originality, relevance, methodology, and contribution to HIV research and clinical practice.
Presentation Format: Accepted abstracts may be selected for oral or poster presentation. The Committee reserves the right to determine the final presentation format based on the scientific evaluation and conference programme requirements.
Presenter Registration: The presenting author of an accepted abstract must complete conference registration and settle the applicable registration fees to be eligible to present at the conference.
Co-Author Approval: The submitting author is responsible for ensuring that all listed co-authors have reviewed and approved the abstract content before submission. The submitting author will serve as the primary contact for all correspondence regarding the abstract.
Submission Deadline: All abstracts must be submitted through the official SSMC HIV Conference 2027 abstract submission platform no later than 01 February 2027. Submissions received after this deadline will not be considered for scientific review.
Scientific Relevance: Abstracts must be relevant to the conference's scientific scope and should address important developments, clinical challenges, innovative practices, or research findings related to HIV medicine and public health.
Acceptance Notification: Authors will be notified of the review outcome through the email address provided during submission. Successful applicants will receive further instructions regarding their assigned presentation format and requirements.
Changes and Withdrawals: Any requests for amendments or withdrawal of submitted abstracts must be communicated to the conference organizing committee. Changes following the submission deadline may be subject to approval.
Final Decision: The Committee reserves the right to accept, reject, or reassign abstracts to the most appropriate presentation category. All decisions made by the committee shall be final.
By proceeding with your submission, you acknowledge that you have read and accepted these terms.
Presenting Author Information
The presenting author is the abstract submitter and is responsible for presenting the e-poster during the poster evaluation session at the conference.
Abstract Details
Your abstract should provide a concise overview of your research, including the objective, methodology, key findings, and conclusion. The content must be clear, well-structured, and limited to 300 words, written in English.
Co- Author Details
Please list a maximum of five (5) co-authors involved in the abstract. In the event of any last-minute changes, only one of the listed co-authors may be appointed as the new presenting author. The original presenting author will remain the primary point of contact for all communications regarding the abstract and poster presentation.
Important: Review all the details of your abstract before submitting.
Copyright 2026. SSMC HIV Conference 2027. All Rights Reserved.
